MedPath

Assessing the likelihood of needing a substance called surfactant for newborns born near their expected delivery date using lung ultrasound

Not Applicable
Completed
Conditions
Surfactant need in late preterm and term infants
Pregnancy and Childbirth
Registration Number
ISRCTN18610513
Lead Sponsor
APHP-Paris Saclay University DMU2
Brief Summary

2024 Results article in https://pubmed.ncbi.nlm.nih.gov/38805223/ (added 14/06/2024)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
157
Inclusion Criteria

All late preterm and term (>=34 weeks' gestation) neonates admitted to the NICU in the first 72 h of life with respiratory failure

Exclusion Criteria

1. Major congenital malformations or chromosomopathies
2. Airleaks preventing a comprehensive lung ultrasound examination
3. Early onset sepsis and hemodynamic instability (defined as need for any inotrope)
4. Congenital surfactant anomalies
5. Pulmonary hypoplasia or congenital lung malformations
6. PPHN
7. Need for surgery in the first week of life

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
pon NICU admission and before surfactant administration (if any):<br>1. Diagnostic accuracy measures (area under the ROC curve and derived accuracy variables). For these outcomes, lung ultrasound scores and need for surfactant replacement will be collected (i.e.: this will allow the raw calculation of true and false positives and negatives).<br>2. Additionally demographics, clinical and monitoring variables usually registered during routine care will be collected.
Secondary Outcome Measures
NameTimeMethod
Oxygenation metrics measured with usual vital monitoring available in each center and its relationship with lung ultrasound score measured using patient records upon NICU admission and before surfactant administration (if any)
© Copyright 2025. All Rights Reserved by MedPath